Sectra’s Post

As we look to the future of clinical lab medicine, Duncan Porter, with 25 years in the industry, shares 8 key trends shaping the field, including the rise of molecular diagnostics and genomics. Duncan highlights how we’re on the cusp of an era of personalized medicine, with genomics leading the way. Learn more about personalized medicine: ➡️ Redefining the genomics landscape: https://lnkd.in/e9nsADs4 ➡️ Driving precision oncology with chemagic tech: https://lnkd.in/eixhBdUE #CLINICAL24 #Genomics #MolecularDiagnostics #PersonalizedMedicine #ClinicalLabs

Let's Get Checked, a technology company, is providing direct telehealth services for germline genetics programs with front and backend support for clinics and providers needing to decrease challenges they face with current labs. We have officially launched our hereditary cancer vertical this week adding to the plethora of at home testing solutions which are increasing compliance and patient engagement across health systems both in the US and abroad. - Crystal clear billing messaging - Ability to offload administrative burden with direct patient engagement - Support for growth and pull through for telegenetics programs - Tackling of large scale testing or backtesting initiatives for those with limited internal resources to do so on their own Let's Get Checked is taking their proven approach to offboard your challenges with current labs and offer scalable diagnostic genetics program support to high risk centers, GC programs and Pop Health/Executive Clinics. You are the experts and we have the tools to support you! Let's chat! bworden@letsgetchecked.com

🚨 Customer Spotlight: MERFISH 2.0 in Action 🚨 💡 MERFISH 2.0 is redefining spatial transcriptomic imaging, delivering exceptional results even with challenging samples like fixed frozen pancreatic ductal adenocarcinoma (PDAC) tissue. Marco Genua from the Fondazione Telethon achieved groundbreaking insights into PDAC using MERFISH 2.0, overcoming the hurdles of suboptimal RNA quality due to high RNase tissue content. 🔥 See how MERFISH 2.0 empowers researchers to overcome technical barriers and gain a deeper understanding of the tumor microenvironment. 📊 Learn more: https://hubs.ly/Q032Qflw0 #SpatialBiology #MERFISH #SpatialTranscriptomics #CancerResearch #PDAC #Vizgen

Last month, Dr. Avni Santani, our Chief Genomics Officer, and Zakkary McNutt, PhD, Senior Scientist in Research And Development, attended the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo. They presented two posters: one on a method we apply to our pharmacogenomic (PGx) test to resolve the diplotype for cases with CYP2D6 duplications, which expands the overall utility of the test, and the other on the validation of our strategy for genetic testing of PMS2 and determining the location of copy number variants detected in the technically challenging PMS2/PMS2CL high homology region. We are excited to continue to shape the future of healthcare with our innovative genomic solutions. To stay up to date on our scientific publications, check out this page: https://lnkd.in/gV-vRqVc

🚀 The countdown to #BiomarkersEU24 is on, and we’re excited to connect with you next week! Stop by Booth #34 and meet our CellCarta team to dive into the latest in #Histopathology, #Genomics, #Proteomics, #FlowCytometry, and more. Whether you're navigating complex clinical trials or tackling translational research, we’re here to discuss how our cutting-edge biomarker platforms can address your challenges and accelerate your breakthroughs. 🔬 Let’s explore how we can help advance your biomarker strategies and drive innovation in precision medicine. See you in Basel! #ClinicalBiomarkers #PrecisionMedicine #CellCarta #BiomarkerInnovation

A great example of the benefits of Spatial sequencing & imaging in Drug Discovery in order to find new drug targets, alongside their exact locations within tissues. Mayr et al. at Boehringer Ingelheim released this paper utilising 10x Genomics' Visium and Xenium spatial technologies to perform deep phenotyping of idiopathic pulmonary fibrosis in lung tissue to help them discover new targets. #targetidentification #drugdiscovery #fibrosis

Multiomic Spatial technologies are making significant impact in Drug Discovery - See the publication below on idiopathic pulmonary fibrosis from Boehringer Ingelheim. Using #Visium & #Xenium from 10x Genomics and Comet from Lunaphore.

Next-generation sequencing is among a portfolio of critical technologies transforming healthcare. See Motion Solutions’ nanopositioning portfolio of proven solutions for next-generation sequencing, microscopy, and molecular diagnostics instrumentation. #genomics #microscopy #nanopositioning #sequencing https://lnkd.in/dMPTiE3

GenQA’s 12 Days of Christmas – Day 2 🎄 March – Molecular Pathology Focus On Series: Webinar 2 – Choosing the Right Assay Our second webinar in the Molecular Pathology series, presented by Dr. Helene Schlecht, Consultant Clinical Scientist and NWGLH Solid Tumour Scientific Lead, Manchester, UK, focused on essential considerations when introducing a new assay into a clinical laboratory.   Key topics covered included: -         Initial considerations (test need, cost, etc.) -         Choosing the appropriate starting material -         Different types of assays -         Implementation requirements You can watch this webinar here https://lnkd.in/gTRRZVkH #EQA #Quality #Genomics #12Highlights #12DaysofChristmas

We're thrilled to announce that our Landscape Gap Analysis, a key initiative led by the Foundation Fighting Blindness Scientific Advisory Board and shaping our 5-year strategic plan, has been published in Translational Vision Science & Technology (TVST)! This milestone publication is featured in TVST’s special issue, Advances in the Cellular and Molecular Pathology of Inherited Retinal Degenerations; Towards Improving Patient Care. This research highlights both the progress made and the unmet needs in addressing inherited retinal diseases and age-related macular degeneration. We're proud to be at the forefront of this critical work. Read the Landscape Gap Analysis at: https://bit.ly/3VJZRn2